View in EDS

The Prognostic Value of CD39 as a Marker of Tumor-Specific T Cells in Triple-Negative Breast Cancer in Asian Women.

Saved in:
Bibliographic Details
Title: The Prognostic Value of CD39 as a Marker of Tumor-Specific T Cells in Triple-Negative Breast Cancer in Asian Women.
Authors: Meng J; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Tan JYT; Duke-NUS Medical School, Singapore, Republic of Singapore; National Cancer Centre Singapore, Singapore, Republic of Singapore., Joseph CR; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Ye J; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Lim JCT; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Goh D; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Xue Y; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Lim X; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Koh VCY; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore., Wee F; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Tay TKY; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore., Chan JY; National Cancer Centre Singapore, Singapore, Republic of Singapore., Ng CCY; National Cancer Centre Singapore, Singapore, Republic of Singapore., Iqbal J; Duke-NUS Medical School, Singapore, Republic of Singapore; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore., Lau MC; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Lim HE; National Cancer Centre Singapore, Singapore, Republic of Singapore., Toh HC; National Cancer Centre Singapore, Singapore, Republic of Singapore., Teh BT; National Cancer Centre Singapore, Singapore, Republic of Singapore., Dent RA; Duke-NUS Medical School, Singapore, Republic of Singapore; National Cancer Centre Singapore, Singapore, Republic of Singapore. Electronic address: rebecca.dent@singhealth.com.sg., Tan PH; KK Women's and Children's Hospital, Singapore, Republic of Singapore; Luma Women's Imaging Centre/Medical Centre, Singapore, Republic of Singapore. Electronic address: tanpuayhoon28@gmail.com., Yeong JPS; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore; Duke-NUS Medical School, Singapore, Republic of Singapore; National Cancer Centre Singapore, Singapore, Republic of Singapore; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore. Electronic address: yeongps@imcb.a-star.edu.sg.
Source: Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2024 Mar; Vol. 104 (3), pp. 100303. Date of Electronic Publication: 2023 Dec 14.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0376617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0307 (Electronic) Linking ISSN: 00236837 NLM ISO Abbreviation: Lab Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0307
DOI:10.1016/j.labinv.2023.100303